Acuren Total Long Term Liabilities 2023-2025 | TIC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Acuren total long term liabilities from 2023 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Acuren total long term liabilities from 2023 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$215.2B
Boston Scientific (BSX)	$153.3B
Stryker (SYK)	$148.6B
EssilorLuxottica (ESLOY)	$131.1B
Medtronic (MDT)	$114.9B
Lonza Group Ag (LZAGY)	$49.8B
Haleon (HLN)	$43.1B
ResMed (RMD)	$37.8B
GE HealthCare Technologies (GEHC)	$34.8B
Agilent Technologies (A)	$32.4B
Terumo (TRUMY)	$23.9B
Koninklijke Philips (PHG)	$23.7B
Insulet (PODD)	$20B
Zimmer Biomet Holdings (ZBH)	$18.4B
Baxter (BAX)	$14.3B
Smith & Nephew SNATS (SNN)	$13.2B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$6.7B
Lantheus Holdings (LNTH)	$4.9B
Prestige Consumer Healthcare (PBH)	$3.7B
Perrigo (PRGO)	$3.7B
Haemonetics (HAE)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.3B
ICU Medical (ICUI)	$3B
LeMaitre Vascular (LMAT)	$1.8B
QuidelOrtho (QDEL)	$1.7B
AtriCure (ATRC)	$1.4B
AdaptHealth (AHCO)	$1.2B